EsophyX TIF (transoral incisionless fundoplication or TIF) is the latest treatment for safely and effectively treating chronic acid reflux disease, also known as gastroesophageal reflux disease (GERD). A completely incisionless procedure, EsophyX TIF reconstructs the anti-reflux barrier to provide a solution to the anatomical root cause of GERD. The procedure is for patients who are dissatisfied with current pharmaceutical therapies or are concerned about the long-term effects of daily use of reflux medications.
TIF is performed endoscopically using the innovative EsophyX surgical device from EndoGastric Solutions. In clinical studies, 79% of patients remained off daily PPIs (proton pump inhibitors) and 70% experienced a total elimination of heartburn at two years after the EsophyX TIF procedure.
What is GERD? In this video, Dr. Cummins explains what GERD is and how the non-invasive TIF procedure treats this condition.
If you have heartburn twice a week or more, you may have GERD. Heartburn is the most common symptom, but you may also experience:
Hoarseness or sore throat
Asthma or asthma-like symptoms
Pain or discomfort in the chest
Sleep disruption (unable to sleep lying down)
Excessive clearing of the throat
Burning in the mouth or throat
Intolerance of certain foods
Dental erosions or therapy-resistant gum disease or inflammation
Normally, after swallowing, a valve between the esophagus and stomach opens to allow food to pass, then it closes to prevent stomach contents from “refluxing” back into the esophagus, causing a burning sensation in the chest. For people who suffer from GERD, the valve is dysfunctional and unable to prevent acid from refluxing into the esophagus.
GERD today is typically treated with medications, such as histamine receptor antagonists (H2 blockers) like Pepcid, Tagamet, and Zantac, and proton pump inhibitors (PPIs) like Nexium, Prilosec, and Protonix. These medications can lose their effectiveness over time. They also don’t treat the underlying root causes of reflux, the deteriorated anatomy of the antireflux barrier, so life-long medication therapy is required. In addition, recent studies on the adverse effects of long-term use of PPIs indicate a significantly higher incidence of hip fractures, particularly among women.
For people who have severe GERD, surgical intervention may be required. Though the conventional laparoscopic procedure has long been proven a very effective long-term solution, it is still “invasive”. It includes incisions and patients must remain in the hospital for up to several days. For that reason, the number of GERD sufferers who undergo the procedure is relatively small.
EsophyX TIF was developed to emulate more invasive surgical techniques, but from within and completely without incisions and visible scars. The FDA cleared EsophyX device is completely incisionless and is performed through the mouth, rather than through an abdominal incision. Typically lasting no more than 30-45 minutes, the procedure is performed under general anesthesia and reconstructs the anti-reflux barrier to restore the competency of the gastroesophageal junction. Most patients can go home the next day and return to work within a few days.
For more information or to view a video on the EsophyX TIF procedure, click here.
(Click on a link below for information on a procedure.)